Document is current
Any future updates will be listed below
-
Authors
Nasraa, Mohamed Hassan https://orcid.org/0000-0002-7524-0805
Bahgat, Mahmoud Mohamed https://orcid.org/0000-0002-6485-8722
Kirschfinik, Michael https://orcid.org/0000-0002-5364-7532
-
Funding
Funding for this research was provided by:
The Deutscher Akademischer Austauschdienst (DAAD) and Institute of Immunology, University of Heidelberg
- License Information
-
More Information
Article History
Received: 1 April 2025
Accepted: 26 May 2025
First Online: 19 June 2025
Change Date: 24 January 2026
Change Type: Update
Change Details: The original online version of this article was revised: The original version of this article unfortunately contained a mistake in abstract section. The abstract section is corrected.
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose .
: This study has been utilized breast cancer cell lines which are commercially available at DSMZ (ACC64 for BT-474 and ACC736 for SK‐BR‐3), and the Research Ethics Committee of Heidelberg University has confirmed that no ethical approval is required.
: Not applicable.
: Not applicable.
